The spinal surgical robots market is experiencing rapid growth as healthcare facilities worldwide adopt robotic-assisted technologies for spine surgeries. These robots enhance precision, reduce ...

The specialist has been performing robot-assisted operations since 2010, consolidating himself as one of the top experts in ...

The stock market heads into an interesting round of earnings, led by Walmart, RIvian, and a key Warren Buffett stock.

Accurate navigation ... and with 3D multimodality imaging, may be the simplest and surest way to advance epilepsy surgery in the near future. JSD has received institutional grant support from Eisai, ...

Shares of Medtronic are benefiting from an improved earnings growth outlook. The company is capturing strong demand for its new lineup of high-tech medical devices. The stock trades at just 16 ...

Medtronic's strong fundamentals, consistent earnings surprises, and accelerating YoY revenue growth support my optimism for the upcoming earnings release and reinforce the "Buy" rating.

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from ...

To get a sense of who is truly in control of Medtronic plc (NYSE:MDT), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie ...

Medtronic is a solid dividend-paying stock. Its stock recently yielded 3.2%. It has increased its payout for nearly 50 years in a row. If you're a dividend investor, I can understand why ...

Shares of NYSE MDT opened at $93.02 on Wednesday. The stock’s 50-day simple moving average is $85.33 and its 200-day simple moving average is $86.72. The company has a debt-to-equity ratio of 0. ...